ClinicalTrials.gg
Not yet recruitingNCT07895602Updated Oct 26, 2026

Effects of Custom 3D Printed Insoles and Short Foot Exercises in Pes Planus

An interventional study of Custom 3D Printed Insoles and Short Foot Exercises in Pes Planus, sponsored by Kutahya Health Sciences University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Kutahya Health Sciences University · Not applicable, Interventional, and Treatment

Updated Oct 26, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Not applicable
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The primary purpose of this study is to evaluate the effects of combining custom 3D-printed medial arch-supported insoles with short foot exercises on foot posture, balance, and gait parameters in individuals with pes planus (flat feet). Furthermore, the study will investigate the impact of this combined intervention on secondary outcomes, including pain levels, health-related quality of life, and functional exercise capacity measured by the 6-Minute Walk Test.

Read the detailed description

Participants will be recruited through personal networks and social media platforms using a snowball sampling method. Potential candidates will be screened for pes planus in accordance with established literature protocols, utilizing the Foot Posture Index-6 (FPI-6) and the Navicular Drop Test.

Eligible individuals who meet the criteria for pes planus will undergo 3D foot scanning. Based on the obtained data, customized medial arch-supported insoles will be manufactured using 3D printing technology. Participants will be instructed to use these custom insoles in their daily lives for a total of 8 weeks. Concurrently, they will be assigned a daily short foot exercise (intrinsic muscle training) program. Each exercise repetition will involve a 5-second hold, and the entire protocol will be maintained for 8 weeks.

All clinical, functional, and biomechanical evaluations-including foot posture, dynamic balance, comprehensive gait and plantar pressure analysis (via the Zebris system), pain intensity, quality of life, and functional walking capacity-will be conducted at two time points: at baseline and at the end of the 8-week intervention period.

For statistical analysis, depending on the normality of data distribution, either a paired t-test or a Wilcoxon signed-rank test will be used to evaluate within-group changes between baseline and week 8. To determine the magnitude of the intervention effect, Cohen's d effect sizes for dependent measures will be calculated and reported alongside 95% confidence intervals.

02

Conditions studied

  • Pes Planus

Browse trials for

03

In context

Flatfoot

171 studies on the registry are indexed under Flatfoot; 42 are open to participants now.

This study's planned enrollment of 54 is above the median of 37 across 124 interventional studies indexed under Flatfoot.

Browse Flatfoot studies →

Lead sponsor

Kutahya Health Sciences University is the lead sponsor of 216 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 and 35 years.
  • Presence of pes planus, defined as a Navicular Drop test value > 10 mm and a Foot Posture Index-6 (FPI-6) score between +6 and +12.
  • Willingness to volunteer for the study and provide written informed consent.

Exclusion criteria

Exclusion Criteria:

  • Presence of rigid pes planus.
  • Hallux valgus.
  • Hallux rigidus.
  • Calcaneal spur (heel spur).
  • History of any neurological, cardiovascular, or systemic diseases.
  • History of any orthopedic disease affecting the lower extremities.
  • History of lower extremity surgery.
  • Body Mass Index (BMI) ≥ 30 kg/m².
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
54 participants (estimated)

Study arms

  • Experimental
    Insole and Exercise Group

    All participants in this group will receive custom 3D printed insoles and perform a short foot exercise program.

    Other: Custom 3D Printed Insoles and Short Foot Exercises

Interventions

  • OtherCustom 3D Printed Insoles and Short Foot Exercises

    The intervention consists of a combined biomechanical and active rehabilitation approach for individuals with pes planus: 1. Custom 3D Printed Insoles: The participants' feet will be 3D scanned, and custom insoles will be manufactured using 3D printing technology. Participants will be recommended to use these personalized insoles during their daily activities for a total of 8 weeks. 2. Short Foot Exercises (SFE): Participants will perform a short foot exercise (foot core / intrinsic muscle) program aimed at increasing intrinsic foot muscle activation. The exercise protocol will be performed daily for 8 weeks, with each repetition held for five seconds.

06

What researchers measure

Primary outcomes

  1. Foot Posture Index-6 (FPI-6)

    Assesses foot posture across 6 criteria. Total scores range from -12 (highly supinated) to +12 (highly pronated).

    Time frame: Baseline and 8 Weeks

  2. Navicular Drop Test (NDT)

    Assesses medial longitudinal arch height difference (in mm) between seated (non-weight bearing) and standing (weight bearing) positions. Higher values indicate increased pronation.

    Time frame: Baseline and 8 Weeks

  3. Modified Star Excursion Balance Test (MSEBT)

    Evaluates dynamic balance by measuring the maximum reach distance (in cm) in three directions: anterior, posteromedial, and posterolateral.

    Time frame: Baseline and 8 Weeks

  4. Spatiotemporal Gait and Plantar Pressure Parameters

    Evaluated using the Zebris system. Includes gait speed (m/s), cadence (steps/min), stride length (cm), stance percentage (%), and plantar pressure parameters (e.g., peak pressure, contact area).

    Time frame: Baseline and 8 Weeks

Secondary outcomes

  1. Numeric Pain Rating Scale (NPRS)

    Assesses pain intensity on an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: Baseline and 8 Weeks

  2. 36-Item Short Form Health Survey (SF-36)

    Assesses health-related quality of life across 8 domains. Subscale scores are transformed to a 0 to 100 scale, where higher scores indicate better health status.

    Time frame: Baseline and 8 Weeks

  3. 6-Minute Walk Test (6MWT) and Modified Borg Scale

    Evaluates functional capacity by measuring the total distance walked in 6 minutes (in meters). Perceived exertion is assessed before and after the test using the Modified Borg Scale (0-10 scale; higher scores indicate greater exertion).

    Time frame: Baseline and 8 Weeks

07

Study locations

1 site
  • Kutahya Health Science University
    Kütahya, Turkey (Türkiye)
    • Emrah Afsar, Phd · Contact · emrah.afsar@ksbu.edu.tr · 5062527008
    • Emrah Afsar, Phd · Principal investigator
    • Zeynep Sena Namaz, MSc · Sub investigator
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07895602
Responsible party
Emrah Afsar (Assistant Professor, Kutahya Health Sciences University) — Principal investigator
First posted
Oct 26, 2026
Start date
Oct 26, 2026 (estimated)
Primary completion
Oct 26, 2027 (estimated)
Completion
Dec 26, 2027 (estimated)
Last update
Oct 26, 2026

Study contacts

Emrah Afsar, Phd
Contact
emrah.afsar@ksbu.edu.tr
5062527008
Ayse Kocak Sezgin, Phd
Contact
ayse.kocaksezgin@ksbu.edu.tr
+90 5072243706
Emrah Afsar, Phd
principal investigator · Kutahya Health Science University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion